| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 06/06/2002 | WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 06/06/2002 | US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
| 06/06/2002 | US20020068349 Nucleotide sequences coding enzymatic polypeptide for use in the generation of trehalose |
| 06/06/2002 | US20020068330 Composition for use in the propagation of bacteria |
| 06/06/2002 | US20020068329 Fusion proteins for prodrug activation |
| 06/06/2002 | US20020068070 High molecular weight major outer membrane protein of moraxella |
| 06/06/2002 | US20020068059 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 06/06/2002 | US20020068053 Process for the production of anti-tumor Th1 cells |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2430077A1 Modified arginine deiminase |
| 06/05/2002 | EP1211319A2 Gene transfer into pancreatic and biliary epithelial cells |
| 06/05/2002 | EP1211315A1 Recombinant vectors for producing HCV envelope proteins |
| 06/05/2002 | EP1211311A2 Cord blood-derived activated lymphocytes and preparations containing said lymphocytes |
| 06/05/2002 | EP1210448A1 Recombinant hsv-1 and live viral vaccines |
| 06/05/2002 | EP1210445A2 Recombinant microorganisms |
| 06/05/2002 | EP1210442A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS |
| 06/05/2002 | EP1210417A2 Plant sterol acyltransferases |
| 06/05/2002 | EP1210410A2 Metal binding compounds and their use in cell culture medium compositions |
| 06/05/2002 | EP1210407A1 Bacterial consortium ebc1000 and a method using the bacterial consortium ebc1000 for remedying biologically recalcitrant toxic chemicals contained in industrial wastewater, waste materials and soils |
| 06/05/2002 | EP1210406A2 Flocculation of cell material |
| 06/05/2002 | EP1210102A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/05/2002 | EP0724637B2 Corticotropin-releasing factor 2 receptors |
| 06/05/2002 | EP0656419B1 Method for highly purifying human serum albumin |
| 06/05/2002 | EP0642516B1 Macrocyclic immunomodulators |
| 06/05/2002 | CN1352688A Mutant 1,3-propanediol dehydrogenase |
| 06/05/2002 | CN1352687A A variant of c6 beta-chemokine leukotactin-1 (shLKn-1) with enhanced biological activity |
| 06/05/2002 | CN1352651A Method for inhibiting macrophage infiltration using monoconal anti-alpha-D-antibodies |
| 06/05/2002 | CN1352650A Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 06/04/2002 | US6399583 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains, process for production and uses thereof |
| 06/04/2002 | US6399567 Cyclic hexapeptides having antibiotic activity |
| 06/04/2002 | US6399382 Synthase catalyst biosynthesis |
| 06/04/2002 | US6399381 Mixture of inorganic salts, amino acids, amine, vitamin c, dexamethasone, calcium salt, retinoic acid, triiodothyronine, hydrocortisone, pituitary gland extract, transferrins and epidermal growth factor |
| 06/04/2002 | US6399376 Modulation of vascular cell adhesive molecule expression through oligonucleotide interactions |
| 06/04/2002 | US6399339 Simple and efficient process using alcohol dehydrogenase in presence of a cofactor |
| 06/04/2002 | US6399331 Method for culturing recombinant cells |
| 06/04/2002 | US6399330 Nucleotide and amino acid sequences of crystal/insecticidal proteins; active against japanese beetle and red flour beetle; biological pest control |
| 06/04/2002 | US6399321 Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT |
| 06/04/2002 | US6399320 Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399066 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/04/2002 | US6399065 Methods for modulating SLAM-expressing T cells |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 06/04/2002 | US6399053 Methods of enhancing bioactivity of chemokines |
| 06/04/2002 | CA2361950A1 Antibiotics g 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/04/2002 | CA2237805C Nucleic acid molecule encoding a 11-cis retinol dehydrogenase |
| 06/04/2002 | CA2171424C Acylated insulin |
| 06/04/2002 | CA2084384C Dna coding for uricase and process for producing uricase |
| 06/04/2002 | CA2070640C D-pantolactone hydrolase and process for the preparation thereof |
| 06/04/2002 | CA2011450C Recombinant b-chain of the il-2 receptor |
| 06/04/2002 | CA1341364C Single polypeptide chain binding molecules |
| 05/30/2002 | WO2002042842A2 A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels |
| 05/30/2002 | WO2002042480A2 Modified vaccinia ankara virus variant |
| 05/30/2002 | WO2002042471A2 Methods and materials for the synthesis of organic products |
| 05/30/2002 | WO2002042336A2 Fgf-affinity chromatography |
| 05/30/2002 | WO2002000663A3 Polycyclic xanthones as antibiotics |
| 05/30/2002 | WO2001096577A8 Production of secreted polypeptides |
| 05/30/2002 | WO2000037669A3 Non-continuous process for the production of vitamin b12 |
| 05/30/2002 | US20020066119 Regulatory sequences for use in generation of disease and damage resistant plants |
| 05/30/2002 | US20020065403 New nucleotide sequences which code for pck gene |
| 05/30/2002 | US20020065398 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
| 05/30/2002 | US20020065393 Human hypoxanthine- (guanine) phosphoribosy1 transferase-2 |
| 05/30/2002 | US20020065392 Methods for production of protein |
| 05/30/2002 | US20020065316 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 05/30/2002 | US20020065238 EPO primary response gene, EPRG3pt |
| 05/30/2002 | US20020064865 Crystal protein for use in bological pest control |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064812 Plasmid for use in the treatment of blood disorders |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
| 05/30/2002 | US20020064534 Herpesvirus preparations and their uses |
| 05/30/2002 | EP1144670A3 Non-continuous process for the production of vitamin b12 |
| 05/30/2002 | CA2430270A1 Methods and materials for the synthesis of organic products |
| 05/30/2002 | CA2429567A1 A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels |
| 05/30/2002 | CA2421151A1 Modified vaccinia ankara virus variant |
| 05/29/2002 | EP1209235A1 Expression vector for fusion gene and method for producing immobilized enzyme |
| 05/29/2002 | EP1209230A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 05/29/2002 | EP1209167A1 Method of producing a biosensor protein capable of regulating a fluorescence property of the modified green fluorescent protein therein, and the biosensor protein produced by the method |
| 05/29/2002 | EP1208214A2 Genetically engineered bleb vaccine |
| 05/29/2002 | EP1208208A2 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) |
| 05/29/2002 | EP1208207A2 Method for producing a channel-forming protein |
| 05/29/2002 | EP1208205A2 Methods for producing l-amino acids by increasing cellular nadph |
| 05/29/2002 | EP1208202A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208192A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 05/29/2002 | EP1208190A1 Rapid growing microorganisms for biotechnology applications |
| 05/29/2002 | EP1207797A1 Method and apparatus for intracellular electro-manipulation |
| 05/29/2002 | EP1002095B1 Improved protein expression strains |
| 05/29/2002 | EP0826311B1 Oral composition for animals |
| 05/29/2002 | EP0752002B1 Inhibition of arterial smooth muscle cell proliferation |
| 05/29/2002 | CN1351660A directed evolution of microorganisms |
| 05/29/2002 | CN1351658A Subtilase enzymes of the 1-S1 and 1-S2 sub-groups having at least one additional amino acid residue between positions 97 and 98 |
| 05/29/2002 | CN1351652A Strain of i(bacillus) pumilus for controlling plant diseases |
| 05/29/2002 | CN1351171A Microbial method for preparing L-ascorbic acid and D-isoascorbic acid |
| 05/29/2002 | CN1085728C Microorganism, medium and process for preparing hyalurohic acid |
| 05/28/2002 | US6395711 Macrolides with antitumor activity |
| 05/28/2002 | US6395542 Exposing immortalized intestinal tract cells, with an agent that does not express tumor markers, and expresses metabolic markers and is capable of adhering in vitro to a lactic acid strain of bacterium; determine mutagenic, toxic effects |
| 05/28/2002 | US6395534 White rot-lignin-modifying fungus Flavodon flavus and a process for removing dye from dye containing water or soil using the fungus |